文献速递新发突发、热带与寄生虫病

孕妇磺胺多辛-乙胺嘧啶化学预防对携带I431V突变的新型恶性疟原虫dhps五重突变体选择的影响

Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation.
PubMed 文献 · J Antimicrob Chemother · 2023-01-01

该研究对喀麦隆雅温得159例患症状性疟疾孕妇的恶性疟原虫pfdhfr和pfdhps基因进行测序,其中70例孕期已服用磺胺多辛-乙胺嘧啶(SP)、89例从未服用。结果显示vagKgs等位基因在SP+组显著过表达(21.4% vs 3.4%,P<0.001),CirnI/vagKgs单倍型在IPTp-SP组强烈过表达,提示该突变体对SP高度耐药。

要点

  • SP+组vagKgs五重突变体占21.4%,未用药组占3.4%,差异显著(P<0.001)。
  • ISgKAA突变体在SP+组占48.6%、未用药组占64.0%,差异接近显著(P=0.0503)。
  • IPTp-SP组CirnI/vagKgs单倍型强烈过表达,提示该突变体对SP高度耐药。

核心结论

  • 在IPTp-SP孕妇组中观察到CirnI/vagKgs单倍型强烈过表达,提示该突变体对SP高度耐药。
  • 这可能不仅损害IPTp-SP的效果,还可能影响目前广泛实施的幼儿季节性疟疾化学预防。

研究设计与样本

  • 对喀麦隆雅温得患症状性疟疾的孕妇进行pfdhfr和pfdhps基因测序,比较接受与未接受IPTp-SP两组。
  • 共评估159例患者,其中70例孕期已服用SP、89例从未服用SP。

主要发现

  • 仅vagKgs等位基因在SP+组显著过表达(21.4% versus 3.4%;P < 0.001)。
  • ISgKAA突变体在该地区广泛分布且已知对SP敏感性较低,在SP+组趋于较少(48.6% versus 64.0%;P = 0.0503)。
  • 在IPTp-SP孕妇组中观察到CirnI/vagKgs单倍型强烈过表达。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A new mutation in the Plasmodium falciparum dihydropteroate synthetase gene (pfdhps), I431V, has been identified in several countries of Central and West Africa. This mutation is mostly found in association with four other SNPs on pfdhps (S436A, A437G, A581G and A613S), forming a quintuple mutant (vagKgs) and almost always associated with the Plasmodium falciparum dihydrofolate reductase gene (pfdhfr) CirnI (C50R, N51I, S108N) triple mutant. To date, nothing is known about the impact of this new pfdhps genotype on sulfadoxine-pyrimethamine (SP) resistance. OBJECTIVES: We sought to assess the prevalence of this pfdhps vagKgs quintuple mutant in two groups of pregnant women with malaria, one that took intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and one that did not. METHODS: The pfdhfr and pfdhps genes from Plasmodium falciparum isolates collected in Yaoundé (Cameroon) from pregnant women with symptomatic malaria under IPTp-SP or not, were sequenced. RESULTS: Of 159 patients evaluated, 70 had already taken SP during pregnancy and 89 had never taken SP. Only the vagKgs allele was significantly overrepresented in the SP+ group (21.4% versus 3.4%; P < 0.001), whereas the ISgKAA mutant, widely distributed in this area and known to be less susceptible to SP, tended to be less abundant in this group (48.6% versus 64.0%; P = 0.0503). CONCLUSIONS: We found a strong overrepresentation of the CirnI/vagKgs haplotype in the IPTp-SP pregnant group, suggesting a high level of resistance of this mutant to SP. This could compromise not only the effectiveness of IPTp-SP but also the seasonal malaria chemoprevention of young children, now widely implemented.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Cohen O, Guemas E, Menard S, et al. Effect of sulfadoxine-pyrimethamine chemoprophylaxis in pregnant women on selection of the new P. falciparum dhps quintuple mutant carrying the I431V mutation. J Antimicrob Chemother. 2023. PMID: 36611259. doi:10.1093/jac/dkac432

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。